EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

InfoBionic’s MoMe Kardia remote ECG monitor is an example of the newer generation devices that are replacing traditional Holter monitors. It has a single button for patients to create an alert when they are experiencing arrhythmia symptoms.

InfoBionic’s MoMe Kardia remote ECG monitor is an example of the newer generation devices that are replacing traditional Holter monitors. It has a single button for patients to create an alert when they are experiencing arrhythmia symptoms.

Feature | ECG Wireless Remote Access | August 30, 2019 | Stuart Long and Colin Movsowitz, M.D.
Until recently, cardiologists trying to diagnose and treat arrhythmias have had to deal with technological limitations...
The Apple Watch is being used to help identify and track Afib in the general population.

The Apple Watch is being used to help identify and track Afib in the general population.  

Blog | Wearables | August 29, 2019
  Atrial fibrillation, or Afib, kills about 130,000 people worldwide every year. It also affects 3 to 6 million people...
Lenox Hill Hospital Opens New Heart Rhythm Center
News | EP Lab | August 27, 2019
August 27, 2019 – Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to the...
FDA Approves Barostim Neo System for Advanced Heart Failure Patients. Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels.

Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.

Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the...
Computer Simulations May Treat Most Common Heart Rhythm Disorder

The OPTIMA (Optimal Target Identification via Modelling of Arrhythmogenesis) simulator uses contrast-enhanced MRI scans to create personalized digital replicas of a patient's heart to guide catheter abation for atrial fibrillation. Image courtesy of Patrick M. Boyle and Natalia A. Trayanova.

News | EP Mapping and Imaging Systems | August 19, 2019
August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper...
Damaged Hearts Rewired With Nanotube Fibers

Researchers at Texas Heart Institute and Rice University have confirmed that flexible, conductive fibers made of carbon nanotubes can bridge damaged tissue to deliver electrical signals and keep hearts beating despite congestive heart failure or dilated cardiomyopathy or after a heart attack. Image courtesy of Texas Heart Institute.

News | EP Lab | August 15, 2019
August 15, 2019 — Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues...
Abbott Recalls Ellipse Implantable Cardioverter Defibrillators Due to Exposed Aluminum Wires
News | Leads Implantable Devices | August 05, 2019
August 5, 2019 — Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical...
Cardiac Device Complications Vary Widely Among Hospitals
News | EP Lab | July 31, 2019
July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...
Videos | EP Lab | July 26, 2019
Mark Ibrahim, M.D., FACC, assistant professor of medicine and radiology, associate program director, advanced cardiac...
Videos | EP Lab | July 25, 2019
Pierre Qian, MBBS, cardiac electrophysiologist fellow, Brigham and Women's Hospital, explains how his facility is...
Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.

Feature | Atrial Fibrillation | July 24, 2019
July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm. It is treated either with medications or...
New Technology Improves Atrial Fibrillation Detection After Stroke
News | Atrial Fibrillation | July 19, 2019
July 19, 2019 — A new method of evaluating irregular heartbeats outperformed the approach that’s currently used widely...
Charge Density Mapping Eliminates Repeat Ablation for Atrial Fibrillation at One Year
News | EP Mapping and Imaging Systems | July 15, 2019
July 15, 2019 — Acutus Medical announced the publication of the UNCOVER AF study in Circulation: Arrhythmia and...
Researchers File Patent for Tiny Blood Flow Sensor

Image courtesy of Flinders University

News | Implantable Cardiac Monitor (ICM) | July 09, 2019
July 9, 2019 — South Australian researchers are developing a tiny fiber-optic sensor, which has the potential to change...
Innovative Health Receives FDA Clearance to Reprocess Pentaray Nav Eco High-density Mapping Catheter
News | EP Mapping and Imaging Systems | July 05, 2019
July 5, 2019 — Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug...